Bilcare Ltd., service provider to the pharmaceutical companies spanning across their value chain from drug discovery to market, has achieved better performance in the quarter ended of June 2007. Its net profit has increased by 21.8 per cent to Rs 13.54 crore from Rs 11.12 crore in the same period of last year. Whereas company's, net sales went up by 27.5 per cent to Rs 92.88 crore from Rs 72.87 crore in the corresponding period of last year. The company's EPS worked out to Rs 8.97 as against Rs 7.83 in the corresponding quarter of the previous year.

"Bilcare has already started reaping the rewards of our investments in creating a global infrastructure to meet the key challenges of big pharma worldwide," said, Mohan Bhandari, chairman Bilcare Ltd. The Research Service business has expanded its reach globally with service centres being established at multiple sites. This has resulted in signing agreement with some of the major global pharma companies for their Research Service requirements. Bilcare has filed three patents on packaging innovations addressing product identity and other multiple consumer concerns like counterfeit and compliance.

Bilcare Research Academy in association with ACRP, US, has launched its first centre to offer one year Post Graduate Programme in "Clinical Research Management". The first batch has already started in its Pune centre.